Docs, Drugmakers Call Medicare Pay Experiment Unlawful

Law360, New York (May 9, 2016, 8:35 PM ET) -- Doctors and drugmakers launched intense attacks Monday on a controversial proposal to overhaul drug payments in Medicare Part B, accusing regulators of overstepping their powers.



The criticism came as a deadline passed Monday to comment on a major pilot project floated in March by the Centers for Medicare and Medicaid Services. The project would test alternative reimbursement models under Part B, which spends $20 billion annually on prescription drugs, often pricey injectables for serious diseases.



Some of the fiercest attacks came from the Community Oncology Alliance,...

To view the full article, register now.